• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·ANURAS.NS
Share

Anupam Rasayan India Ltd Stocks

₹ 1267.5Last Updated 17.07.2026

Issuer Rating

4/7
Performance

Modest

Risk

Low

Recommendation

Hold

Market Cap

₹ 1.51B

₹ 1267.5
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and active ingredients crucial for the agrochemical sector, alongside compounds for antibacterial and ultraviolet protection applications in the personal care industry. Additionally, it provides essential intermediates and key starting materials vital for active pharmaceutical ingredients. Beyond these life science applications, Anupam Rasayan also supplies other specialized chemicals to various end-user segments, such as specialty pigments, dyes, and polymer additives. The company distributes its products both domestically and through exports.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of ANURAS.NS is 1067 and suggests 15.8% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.07.2026 19:01

The Motley Fool called Wall Street's expectations for Oklo's stock growth "overblown"

20.07.2026 17:35

Yemeni Houthis have announced a blockade of Saudi Arabian shipping in the Red Sea

20.07.2026 16:56

Ryanair lost a third of its profits due to the war in the Middle East. Its stock plummeted 7%.

20.07.2026 16:55

Small-cap rival Nebius plummeted by a third despite its partnership with Nvidia

20.07.2026 16:17

TSMC has predicted “long-term demand” for chips. The sector is currently in a “bear market.”

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026